Treatment of Kimura disease with intravenous immunoglobulin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22106083.
- Also identified by DOI 10.1542/peds.2010-1623.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Kimura disease is an uncommon chronic inflammatory condition of unknown etiology and is characterized by painless subcutaneous nodules, usually affecting the head and neck, eosinophilia, and markedly elevated immunoglobulin E levels. Several reports have described the main modalities of treatment; both corticosteroids and surgery have provided good results, but occasionally corticosteroids cannot be tapered as the disease flares up. We report here the case of an 8-year-old boy diagnosed with Kimura disease who was successfully treated with 1 dose of intravenous immunoglobulin as a steroid-sparing agent.
Medical subject headings
- Angiolymphoid Hyperplasia with Eosinophilia
- Immunoglobulins, Intravenous
- Immunologic Factors